CareToLive Citizen Petition for FDA to Reconsider Provenge Approval Update
January 23rd, 2008 | Posted by CTLOn Thursday, 1/17/08, CareToLive received a response to the CTL Citizens Petition filed on July 27, 2007.
Read the FDA response to the CareToLive petition for the FDA to reconsider the decision to delay the approval of the immunotherapy Provenge (click this link)
Today 1/23/08 CTL received a call back from the person at the FDA that had previously faxed us the response to the CTL Citizen Petition.
She indicated that she could not give any kind of timeline on the reconsideration of the failure to approve Provenge. She was asked who could and if anyone else at the FDA could elaborate on the short letter received by CTL from Jesse Goodman, or if anyone could pinpoint a time frame.
She was an extremely nice lady but we sensed that she had strict marching orders.
She stated that “there is a group of people actively reviewing the matter”.
She was asked if the group consisted entirely of people from CBER and she said she was not comfortable answering that.
She was asked if Jesse Goodman was one of the people involved in the group considering the Petition. Again she indicated she was not able to confirm or deny that.
After a few similar type of questions it was sensed that she was very uncomfortable and CTL stated to her that we understood she was in a tough spot and understood that she was not able to tell us more. With that she was thankful.
CTL is sure she was told exactly what to say and not to deviate from what she was specifically told to disclose.
READ OUR PETITION HERE
Petition for the FDA to Reconsider the Failure to Approve Provenge (click this link)
Popularity: 34%
Tags: Care To Live, CareToLive, Dendreon, Jesse Goodman, Petition, Prostate Cancer, provenge